Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.
Merry
S
S
CRC Department of Medical Oncology, University of Glasgow, UK.
Flanigan
P
P
Schlick
E
E
Freshney
R I
RI
Kaye
S B
SB
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004317:Doxorubicin / Q000008:administration & dosage; D004351:Drug Resistance; D051379:Mice; D014407:Tumor Cells, Cultured / Q000187:drug effects*; D014700:Verapamil / Q000008:administration & dosage / Q000031:analogs & derivatives
D004317:Doxorubicin; C016904:norverapamil; D014700:Verapamil